SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-285878
Filing Date
2019-11-06
Accepted
2019-11-06 16:04:12
Documents
21
Period of Report
2019-11-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d825095d8k.htm   iXBRL 8-K 26825
2 EX-99.1 d825095dex991.htm EX-99.1 9559
6 GRAPHIC g825095ex99_1s1g1.jpg GRAPHIC 123561
7 GRAPHIC g825095ex99_1s2g1.jpg GRAPHIC 457813
8 GRAPHIC g825095ex99_1s3g1.jpg GRAPHIC 365848
9 GRAPHIC g825095ex99_1s4g1.jpg GRAPHIC 232953
10 GRAPHIC g825095ex99_1s5g1.jpg GRAPHIC 156116
11 GRAPHIC g825095ex99_1s6g1.jpg GRAPHIC 194784
12 GRAPHIC g825095ex99_1s7g1.jpg GRAPHIC 355605
13 GRAPHIC g825095ex99_1s8g1.jpg GRAPHIC 353499
  Complete submission text file 0001193125-19-285878.txt   3249360

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aeri-20191106.xsd EX-101.SCH 3080
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aeri-20191106_lab.xml EX-101.LAB 18140
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aeri-20191106_pre.xml EX-101.PRE 11415
17 EXTRACTED XBRL INSTANCE DOCUMENT d825095d8k_htm.xml XML 3420
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36152 | Film No.: 191196245
SIC: 2836 Biological Products, (No Diagnostic Substances)